Skip to NavigationSkip to content

Pharmafile - Medical Communications News

Boehringer Ingelheim and Eli Lilly’s Trajenta (linagliptin) met its primary endpoint in a recent trial, it has emerged, proving itself non-inferior...
- Janssen's esketamine drug recommended by FDA panel for depression - Researchers find new type of cell membrane which causes cancer cells to explode...
NICE has announced its decision to authorise the use of Roche’s Perjeta (pertuzumab) on the NHS for the treatment of HER2-positive breast cancer...
AstraZeneca is retiring the MedImmune brand as part of a restructuring that will see biologics integrated into two new R&D units.
Lundbeck and Otsuka’s treatment for bipolar disorder, Rexulti, failed to achieve its primary endpoint in two separate Phase 3 trials.
A team of researchers have devised a new way to accurately detect residual HIV in the body’s immune cells, allowing for better evaluation of the...
The FDA has warned against the link between breast implants and anaplastic large cell lymphoma, noting that at least nine patients have died as a...
-GSK buys Merck KGaA's cancer immunotherapy for $4.2 billion -400 Pfizer employees set to strike over pensions -Takeda ordered to pay Bayer $155.19...
The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British Pharmaceutical Industry (ABPI...
US multinational Johnson & Johnson has announced that it will include the price of its medicines in TV commercials for its drugs.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches